Dr Sunni Yuan is a consultant endocrinologist dedicated to evidence-based, individualised and compassionate care for adults across the full range of endocrine conditions. She has a particular passion for diabetes — including the use of emerging technology to improve glycaemic outcomes and quality of life — as well as thyroid disease, women's hormonal health, and pituitary disorders.
Dr Yuan graduated in medicine from the University of Melbourne and completed specialist physician training in general medicine and endocrinology at St Vincent's Hospital Melbourne and Alfred Health. She is a Fellow of The Royal Australasian College of Physicians (FRACP). Her research into the use of technology to improve glycaemic outcomes in both Type 1 and Type 2 diabetes has been published in international journals and presented at national and international conferences.
Dr Sunni Yuan completed a Bachelor of Biomedicine with Honours at the University of Melbourne before undertaking her medical degree (MD) at the same institution. She subsequently trained in general medicine and endocrinology at St Vincent's Hospital Melbourne and Alfred Health, two of Melbourne's leading academic health services, before being awarded Fellowship of The Royal Australasian College of Physicians (FRACP).
Dr Yuan provides specialist care across the full breadth of adult endocrinology. She has developed a particular expertise in diabetes — both type 1 and type 2 — with a strong interest in the use of technology to optimise glycaemic control and improve patient experience. This includes continuous glucose monitoring (CGM), insulin pump therapy, and automated insulin delivery (hybrid closed-loop) systems. She is committed to helping patients access and get the most from contemporary diabetes technologies, and to translating advances in this rapidly evolving field into practical, personalised management plans.
Beyond diabetes, Dr Yuan has a strong interest in thyroid disorders, women's hormonal health — including polycystic ovary syndrome, menstrual irregularity and preconception care — and pituitary disease. She takes a thorough, unhurried approach and places particular value on ensuring that patients understand their condition and feel genuinely involved in decisions about their care.
Dr Yuan sees patients at Suite 49, Cabrini Malvern, and provides inpatient endocrinology consultation at Cabrini Malvern Hospital. She is committed to close collaboration with referring general practitioners and allied health providers to support coordinated, ongoing care.
Advanced training in Endocrinology and General Medicine at St Vincent's Hospital Melbourne and Alfred Health.
Graduate medical degree from one of Australia's leading research universities.
Undergraduate degree in biomedical science, completed with Honours, providing a strong foundation in physiology, pathology and clinical research.
Dr Yuan's clinical interests include the following areas, which she has developed through her training at St Vincent's and Alfred Health and through an ongoing interest in clinical research and emerging evidence.
Comprehensive diabetes management including insulin optimisation, continuous glucose monitoring (CGM), insulin pump therapy, and hybrid closed-loop systems. Diabetes in pregnancy and preconception planning.
Hypothyroidism, hyperthyroidism (including Graves' disease), thyroid nodules and goitre, thyroid cancer follow-up, and thyroid conditions in pregnancy.
Polycystic ovary syndrome (PCOS), menstrual irregularity, fertility and preconception endocrine care, menopausal hormonal health, and osteoporosis.
Pituitary tumours, hypopituitarism, prolactinoma, acromegaly, and pituitary incidentalomas.
Comprehensive care across the full breadth of adult endocrinology, including parathyroid disorders (hyperparathyroidism, hypercalcaemia), adrenal conditions (adrenal incidentaloma, Cushing's syndrome, adrenal insufficiency), osteoporosis and metabolic bone disease, and other endocrine conditions not specifically listed above.
Dr Yuan's research has focused on the use of technology to improve glycaemic outcomes in people living with type 1 and type 2 diabetes — including continuous glucose monitoring, insulin pump therapy, and hybrid closed-loop systems. Her work has been published in international peer-reviewed journals and presented at national and international conferences.
